The Role of Airway pH in Asthma and Respiratory Viral Infections
Date: April 18, 2024
Time: 3:30 - 4:30 pm
Presented by
Michael D. Davis, PhD
Associate Research Professor of Pediatrics
Indiana University School of Medicine
On April 18, 2024, 40 faculty, administrators and staff attended the CHPPRR Lecture series to hear Dr. Michael Davis from Indiana University discuss airway pH homeostasis and the relevance of airway pH and airway pH modulation in asthma. Dr. Davis also discussed how airway pH modulation has been implicated as a potential mechanistic target for antiviral therapy. This may also benefit asthma management since viral respiratory infections are a leading cause of asthma exacerbation. New data was presented on the potential for airway ph modulation as a treatment for viral respiratory infections as well as asthma exacerbations. Information shared on his work during the pandemic and treatment of viral respiratory infections was inspiring.
Dr. Davis received his PhD in Physiology and Biophysics with a focus in Pulmonary Medicine from Virginia Commonwealth University. His research focus at Indiana University is on airway pH regulation, airway disease pathophysiology and therapeutics, and novel exhaled biomarkers. Dr. Davis also serves as the Chair of Exhaled Breath Aerosols and Condensate for the International Association of Breath Research.
